
|Articles|December 25, 2016
Flurry of FDA Activity Highlights AJPB Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Moves to Restrict Mass-Marketed Compounded GLP-1 Products
2
Bipartisan Legislation Introduced to Control Drug Prices, ‘Corporate Greed’ Within Health Care
3
FDA Approves Drug Labeling Changes to 6 Menopausal Hormone Therapy Products
4
Trispecific Antibody IBI3003 Receives Fast Track Designation for Relapsed or Refractory Multiple Myeloma
5








































